ANIK Live signaler | Maksimer profitt med Getagraph.com

SELG 108214 min ago

@ $23.63

Utstedt: 14 feb 2024 @ 15:30

Avkastning: 10.43%

Forrige signal: feb 13 - 15:30

Forrige signal: Kjøp

Avkastning: 0.60 %

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 19:32):

Stats
Dagens volum	16 972.00
Gjennomsnittsvolum	80 045.00
Markedsverdi	387.51M
EPS	$0 ( 2024-03-13 )
Neste inntjeningsdato	( $-0.190 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.63
ATR14	$0.0780 (0.30%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-15	Levitz Michael L	Buy	51 682	Stock Option (Right to Buy)
2024-03-15	Levitz Michael L	Buy	21 329	Restricted Stock Unit
2024-03-15	Colleran David	Buy	46 875	Stock Option (Right to Buy)
2024-03-15	Colleran David	Buy	19 345	Restricted Stock Unit
2024-03-15	Nunes Anne	Buy	26 442	Stock Option (Right to Buy)

INSIDER POWER
51.59
Last 100 transactions
Buy: 1 044 875 \| Sell: 338 384

Volum Korrelasjon

Lang: -0.01 (neutral)

Kort: -0.05 (neutral)

Signal:(68.069) Neutral

Anika Therapeutics Inc Korrelasjon

10 Mest positive korrelasjoner
RMRM	0.905
BPTH	0.892
GOODN	0.886
RMGC	0.883
MLVF	0.875
BCOV	0.872
ALLT	0.87
WISH	0.868
GOODO	0.868
APTX	0.868

10 Mest negative korrelasjoner
PTRS	-0.908
AAON	-0.874
ULBI	-0.866
CORT	-0.859
PXI	-0.855
STEP	-0.842
PSCE	-0.84
TUR	-0.838
GSHD	-0.837
FTXN	-0.837

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Anika Therapeutics Inc Korrelasjon - Valuta/Råvare

0.71
( moderate )

0.77
( moderate )

0.00
( neutral )

0.57
( weak )

-0.27
( neutral )

-0.73
( moderate negative )

Anika Therapeutics Inc Økonomi

Annual	2023
Omsetning:	$166.66M
Bruttogevinst:	$103.09M (61.85 %)
EPS:	$-5.64

FY	2023
Omsetning:	$166.66M
Bruttogevinst:	$103.09M (61.85 %)
EPS:	$-5.64

FY	2022
Omsetning:	$156.24M
Bruttogevinst:	$93.58M (59.89 %)
EPS:	$-1.020

FY	2021
Omsetning:	$147.79M
Bruttogevinst:	$82.94M (56.12 %)
EPS:	$0.290

Financial Reports:

No articles found.

Anika Therapeutics Inc

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management product family consists of Monovisc, Orthovisc, Cingal, and Hyvisc that are indicated to provide pain relief from osteoarthritis conditions; and joint preservation and restoration product family comprise a portfolio of approximately 150 bone preserving joint technology products, a line of sports medicine soft tissue repair solutions, and orthopedic regenerative solutions products. The company's non-orthopedic product family include HA-based products for non-orthopedic applications, including adhesion barrier products, advanced wound care products, ophthalmic products, and ear, nose, and throat products. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.